Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Devon Weterings

PhD


Postdoctoral Scientist

Research interest:

My current research focuses on how T cells recognise rhabdomyosarcoma (RMS), a rare paediatric soft tissue cancer. I study fusion-derived antigens, which are small protein fragments created by genetic fusion events that are unique to these tumours, along with the T cells that recognise them. By investigating T cell responses to these antigens, I hope to contribute to the development of new cancer vaccines that can help the immune system recognise and target RMS cells.

 

Background:

I completed my BSc in Biochemistry, MSc in Molecular Medicine, and PhD at Imperial College London. During my PhD, I studied T cell responses to the oncoretrovirus HTLV-1 in individuals at high risk of developing adult T cell leukaemia/lymphoma due to suspected premalignant lesions, with the aim of better understanding immune responses during the early stages of cancer development.